You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 15, October 19, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Conflict of Interest
 •Medical Ethics
 •Alert me on articles by topic

Physicians Advising Investment Firms

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In attempting to articulate their condemnation of physicians advising investment firms, Drs Topol and Blumenthal1 invoked an ethical rebuke all readers would recognize—conflict of interest. Consulting to the investment industry by physicians may be worrisome and deplorable, but it is not a conflict of interest.

A conflict of interest occurs when a financial or other secondary interest biases or has the potential to bias a physician’s primary professional aims.2 When there is the lure of money but it cannot distort a physician’s judgment related to the duties of patient care, research, or the teaching of medicine, there may be worries about appearances, but there cannot be a conflict of interest.3

Providing advice to investment companies, even for large amounts of monetary compensation, does not distort or undermine physicians’ judgments regarding patient care, research, or teaching, except in rare circumstances when the individual providing advice is the principal . . . [Full Text of this Article]

Lindsay A. Hampson, BA
lhampson@cc.nih.gov

Ezekiel J. Emanuel, MD, PhD
Department of Clinical Bioethics
The Clinical Center
National Institutes of Health
Bethesda, Md



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Investment analysts and the American Society of Hematology
Steensma
Blood 2008;112:29-33.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.